Clark George C. 4

What Happened
George C. Clark, Vice President and Chief Accounting Officer of Biohaven Ltd. (BHVN), was granted a 50,000-share derivative award on February 27, 2026. The reported acquisition price is $0.00, so the filing shows $0 cash paid for the award; this is a compensation grant (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-02-27; Form 4 filed: 2026-03-03 (filed on time).
• Instrument: derivative award (reported as an award/grant, acquisition price $0.00).
• Amount: 50,000 shares (underlying shares subject to vesting).
• Vesting: Four equal installments on Feb 27 of 2026, 2027, 2028 and 2029, subject to continuous service (per footnote).
• Reported value: $0 on the Form 4 (compensation grant reported as $0 acquisition price).
• Shares owned after transaction: not specified in the information provided.

Context
This was a compensation grant rather than a market purchase or sale, so it reflects company compensation practices more than immediate insider buying/selling. The award vests over four years and requires continued service to receive the underlying shares; it does not indicate any immediate sale of shares.